update of a phase i trial investigating lintuzumab-ac225 plus venetoclax in r/r aml
Published 5 months ago • 61 plays • Length 2:00Download video MP4
Download video MP3
Similar videos
-
1:30
a phase i trial of voruciclib /- venetoclax for the treatment of nhl and aml
-
2:08
inotuzumab ozogamicin & venetoclax in the treatment of b-all: findings from a phase i trial
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
2:05
results from the phase i sal-relax trial: venetoclax plus cytarabine and mitoxantrone in r/r aml
-
2:11
update on phase i/ii study of azacitidine, venetoclax and gilteritinib in patients with flt3 aml
-
3:13
targeting cd38 with a bispecific antibody to treat r/r aml: a phase i trial
-
1:53
jakavi
-
4:32
recent advances in the treatment of lr-mds: commands and imerge trial data
-
3:37
biomarker analysis of luspatercept versus epoetin alfa in lr-mds in the phase iii commands study
-
6:32
a phase i trial of dsp-5336, a novel menin inhibitor, in the treatment of aml
-
2:04
introducing a phase ib/ii trial to evaluate tasquinimod for the treatment of myelofibrosis
-
2:49
results of a phase i trial investigating cynk-001, a placental nk-cell product, in patients with aml
-
1:45
ham-ven as salvage treatment for r/r aml: results from the sal-relax trial
-
1:52
evaluating the efficacy of obinutuzumab, ibrutinib, and venetoclax in richter's transformation
-
3:52
venetoclax & aml
-
2:19
anbal-cel: updated results from phase i study of novel cd19-targeting car-t therapy
-
2:41
onvansertib and decitabine in relapsed/refractory aml
-
1:12
cpx-351 with venetoclax in r/r aml: results of a phase ib study
-
1:28
the role of allogeneic transplantation in patients with aml in the frontline setting
-
4:48
ruxolitinib and decitabine in patients with post-mpn aml
-
3:24
novel agents in higher-risk mds